CPAP effects on leptin and visceral fat in patients with sleep apnea: Double-blind, randomized, controlled trial

P. Lee, C. W. Yu, M. T. Lin, T. T. F. Shih, W. Y. Shau, H. D. Wu, C. T. Tang, S. H. J. Hsu, S. C. Wang, C. J. Yu, P. C. Yang (Taipei, Taiwan)

Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Session: Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Session type: Oral Presentation
Number: 1428
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Lee, C. W. Yu, M. T. Lin, T. T. F. Shih, W. Y. Shau, H. D. Wu, C. T. Tang, S. H. J. Hsu, S. C. Wang, C. J. Yu, P. C. Yang (Taipei, Taiwan). CPAP effects on leptin and visceral fat in patients with sleep apnea: Double-blind, randomized, controlled trial. Eur Respir J 2011; 38: Suppl. 55, 1428

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Visceral adiposity, TNFα, CRP and CPAP effect in patients with sleep apnea – A double-blind, randomized, placebo-controlled trial
Source: Annual Congress 2010 - News from RCT (randomised controlled trials) and epidemiology in sleep apnoea
Year: 2010

Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial
Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019
Year: 2020



Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea
Source: Eur Respir J 2005; 26: Suppl. 49, 723s
Year: 2005

BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN)
Source: Eur Respir J, 58 (5) 2101937; 10.1183/13993003.01937-2021
Year: 2021



A randomised, double-blind, crossover, placebo-controlled trial of a mandibular advancement device for the treatment of snoring and mild obstructive sleep apnoea-hypopnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002

The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial
Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019
Year: 2019



Safety and efficacy of sulthiame in moderate to severe obstructive sleep apnea: a randomized placebo-controlled parallel-group trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



Effects of CPAP treatment on sex hormone levels in patients with obstructive sleep apnoea - data from two randomized, controlled trials
Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects
Year: 2019




AVAPS-AE vs. ST mode: A randomised controlled trial in patients with obesity hypoventilation syndrome
Source: International Congress 2018 – New insights in the management of chronic respiratory failure
Year: 2018



CPAP impact on memory processes in OSA patients, a randomized sham controlled trial
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016

A randomized, cross-over, placebo-controlled study of the effects of CPAP upon oxidative stress and nitrate deficiency in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008

Randomised controlled trial of the effect of CPAP in uncontrolled nocturnal asthmatic patients with OSAS.
Source: International Congress 2017 – CPAP therapy
Year: 2017


A prospective, randomised, controlled trial of CPAP in adults with Down syndrome
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study
Source: Eur Respir J 2014; 44: 140-149
Year: 2014



A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Effects of ghrelin on the dyspnea pattern in cachectic COPD: Exploratory analysis of a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013


OSAS treatment with CPAP: Randomized crossover study comparing tolerance and efficacy with and without humidification
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


Mandibular advancement device versus continuous positive airway pressure for treatment of obstruvtive sleep apnea syndrome: a randomized crossover trial
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial
Source: Eur Respir J 2013; 42: 1244-1254
Year: 2013



Noninvasive ventilation in obesity hypoventilation syndrome: A randomized controlled trial
Source: Annual Congress 2010 - Long-term noninvasive ventilation in the chronic patient: outcome and pathophysiology
Year: 2010